Why is Reata Pharmaceuticals, Inc. (RETA) stock popping high in Pre-Market trading?

XRTX

Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases, announced that it was communicated from the Division of Neurology Products 1 of the FDA focusing on the preliminary review of briefing materials for an approaching Type C meeting focusing on the development program for omaveloxolone […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.